Compare · 2 funds side by side · dividends reinvested

TMED and ARKG

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$6,586ARKG · best of the two

02 / 04

TMED and ARKG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFSectors · Health care0.44%0.47%+16.2%+21.3%[…][…]−11.1%18.7%$34M1.3

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+70.9%+59.0%+30.6%−8.0%−27.5%45.8%$2.2B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: TMED 2025 · ARKG 2014

Head to Head

Swap sides Versus in desk

Head to Head

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF · $34M[…]

TMED

ARKG

ARK Genomic Revolution ETF · $2.2B$6,586

$10,000 five years ago, dividends reinvested · they hold 3.5% in common

TMEDMeasureARKG

+16.2%Year to dateJan 1 → Nov 3+70.9%

+21.3%1 yearTotal return+59.0%

[…]3 years · per year$10,000 became […] · $22,262+30.6%

[…]5 years · per year$10,000 became […] · $6,586−8.0%

0.44%Expense ratio$44 · $75 a year on $10k · lower is better0.75%

0.47%Trailing 12-mo yield$47 · $0 a year on $10k0.00%

−11.1%Worst dropSmaller is better−27.5%

18.7%VolatilityLower is calmer45.8%

TMEDARKG Winner of the row, in its colourEach row: the bigger of the two fills its side

4–2TMED wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

TMED vs ARKG: Top 5 Holdings

Today

TMED

22.3%in top 5

ARKG

in top 535.4%

TMEDStockARKG

not top 5TEM9.8%

not top 5TXG7.5%

not top 5TWST7.4%

6.2%LLY.TOnot top 5

not top 5CRSP5.5%

5.2%UNH.BAnot top 5

not top 5GH5.1%

3.9%PODDnot top 5

3.6%ALNYnot top 5

3.4%TMO.TOnot top 5

Held in common3.5%

End-of-day Nov 3, 2026 · share of each fund

TMED vs ARKG Returns, Every Period

T. Rowe PriceTMED

+21.3%

past year

ARKGARK

+59.0%

past year

TMEDARKGFaded: behind in that period

0–2ARKG wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

TMED vs ARKG

YTD

T. Rowe PriceTMED

+16.2%

ARKGARK

+70.9%

+16.2%Year to date+70.9%

−11.1%Worst drop · 1Y−27.5%

18.7%Volatility · 1Y45.8%

0.5%Yield0.0%

$34.1MAssets$2.2B

3–1TMED wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: TMED, ARKG

Today

0.44%lowest, TMED

FundExpense ratioFee$10k

TMED0.44%$44

ARKG0.75%$75

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: TMED, ARKG

0.47%highest, TMED

FundTrailing yieldYield$10k

TMED0.47%$47

ARKG0.00%$0

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$3most kept, TMED

TMED$47 − $44 = $3

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: TMED, ARKG

Today

3.5%most shared, TMED and ARKG

TMEDARKG

TMED—3.5%

ARKG3.5%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+59.0%ARKG, at 45.8% volatility

TMEDWorst drop−11.1%18.7% vol

ARKGWorst drop−27.5%45.8% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

TMEDARKG

+16.2%Year to date+70.9%

0.5%Yield0.0%

+21.3%Past year+59.0%

0.44%Fee0.75%

2–2level

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026